Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2020		30,515,334
Beginning balance at Dec. 31, 2020	$ 660,104	$ 3,052	$ 11,126	$ 700,304	$ (101,503)	$ 47,125
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to Ebix, Inc.	21,591			21,591
Net loss attributable to noncontrolling interest	(304)					(304)
Cumulative translation adjustment	(3,919)				(3,919)
Vesting of restricted stock (in shares)		43,990
Vesting of restricted stock	0	$ 4	(4)
Share based compensation	1,358		1,358
Common stock dividends paid	(2,321)			(2,321)
Ending balance (in shares) at Mar. 31, 2021		30,559,324
Ending balance at Mar. 31, 2021	676,509	$ 3,056	12,480	719,574	(105,422)	46,821
Beginning balance (in shares) at Dec. 31, 2021		30,683,393
Beginning balance at Dec. 31, 2021	699,554	$ 3,068	15,068	759,208	(122,022)	44,232
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to Ebix, Inc.	19,191			19,191
Net loss attributable to noncontrolling interest	(814)					(814)
Cumulative translation adjustment	(11,284)				(11,284)
Vesting of restricted stock (in shares)		39,981
Vesting of restricted stock	0	$ 4	(4)
Share based compensation	$ 964		964
Forfeiture of certain shares to satisfy exercise costs and the recipients' income tax obligations related to stock options exercised and restricted stock vested (in shares)	(1,107)	(1,107)
Forfeiture of certain shares to satisfy exercise costs and the recipients income tax obligations related to stock options exercised and restricted stock vested	$ (34)	$ 0	(34)
Common stock dividends paid	(2,318)			(2,318)
Ending balance (in shares) at Mar. 31, 2022		30,722,267
Ending balance at Mar. 31, 2022	$ 705,259	$ 3,072	$ 15,994	$ 776,081	$ (133,306)	$ 43,418